Arbelic (telavancin)
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 85 (Table of Contents)
Published: 7 Jul-2007
DOI: 10.3833/pdr.v2007.i85.324 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Telavancin, originally compound 21, was discovered by Theravance using the company’s multivalent drug design technique in a research programme that aimed to fi nd new antibiotics for serious infections caused by Staphylococcus aureus (including multidrug resistant strains) and other Gram-positive pathogens...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS